Ramona Doyle - Feb 4, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: Chief Medical Officer
Signature: /s/ Nathan Hatfield, attorney-in-fact
Stock symbol: RXRX
Transactions as of: Feb 4, 2022
Transactions value $: -$11,183
Form type: 4
Date filed: 2/8/2022, 08:09 PM
Previous filing: Feb 2, 2022
Next filing: Mar 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXRX	Class A Common Stock	Award	$0	+38.5K	+67.15%	$0.00	95.8K	Feb 4, 2022	Direct	F1
transaction	RXRX	Class A Common Stock	Award	$0	+2.39K	+2.5%	$0.00	98.2K	Feb 4, 2022	Direct	F2
transaction	RXRX	Class A Common Stock	Tax liability	-$11.2K	-981	-1%	$11.40	97.2K	Feb 4, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXRX	Stock Option (Right to Buy)	Award	$0	+77K		$0.00	77K	Feb 4, 2022	Class A Common Stock	77K	$11.40	Direct	F3
transaction	RXRX	Stock Option (Right to Buy)	Award	$0	+4.78K		$0.00	4.78K	Feb 4, 2022	Class A Common Stock	4.78K	$11.40	Direct
holding	RXRX	Stock Option (Right to Buy)						694K	Feb 4, 2022	Class A Common Stock	694K	$2.48	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter.
F2	This RSU vested immediately upon the grant date.
F3	The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F4	Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.